Cleared Special

K192236 - Fitmore Hip Stem

K192236 is the FDA 510(k) clearance for Fitmore Hip Stem by Zimmer GmbH. It is a Class 2 Orthopedic device (product code KWY) cleared through the Special 510(k) pathway after a 78-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2019
Decision
78d
Days
Class 2
Risk

K192236 is an FDA 510(k) clearance for the Fitmore Hip Stem. Classified as Prosthesis, Hip, Hemi-, Femoral, Metal/polymer, Cemented Or Uncemented (product code KWY), Class II - Special Controls.

Submitted by Zimmer GmbH (Winterthur, CH). The FDA issued a Cleared decision on November 5, 2019 after a review of 78 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3390 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Zimmer GmbH devices

Submission Details

510(k) Number K192236 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 19, 2019
Decision Date November 05, 2019
Days to Decision 78 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 122d · This submission: 78d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code KWY Prosthesis, Hip, Hemi-, Femoral, Metal/polymer, Cemented Or Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - KWY Prosthesis, Hip, Hemi-, Femoral, Metal/polymer, Cemented Or Uncemented

All 74
Devices cleared under the same product code (KWY) and FDA review panel - the closest regulatory comparables to K192236.
Vario-Cup System
K221794 · Waldemar Link GmbH & Co. KG · Jul 2022
COPAL exchange G hip spacer
K220492 · Heraeus Medical GmbH · Mar 2022
Kyocera Bipolar Hip System
K200709 · Kyocera Medical Technologies, Inc. · Apr 2020
COPAL exchange G Hip and Knee Spacers
K191016 · Heraeus Medical GmbH · Nov 2019
iNSitu Bipolar Hip System
K191297 · Theken Companies, LLC · Sep 2019
Implantcast ic-Bipolar Head System
K191569 · Implantcast GmbH · Aug 2019